Cannabis is inaccurately classified as a Schedule I drug, equated with heroin, despite its accepted medical use in 38 states. This misclassification hinders research, access to medical care, and economic growth. Medical evidence supports the efficacy of cannabis for various conditions like chronic pain and PTSD. Rescheduling cannabis to Schedule III would recognize its medical potential without legalizing it for recreational use. It would also facilitate research and improve patient access by reducing existing barriers within federal regulations.
Cannabis is classified as a Schedule I drug, labeling it as having no accepted medical use and a high potential for abuse, alongside drugs like heroin.
Despite overwhelming medical evidence and bipartisan public support, the federal government maintains cannabis is as dangerous as heroin, obstructing science, medical care, and economic growth.
Moving cannabis from Schedule I to Schedule III would not legalize it for recreational use, but would acknowledge its medical potential and reduce research obstacles.
In 38 states and Washington, D.C., medical cannabis has become integral to treating conditions like chronic pain, epilepsy, PTSD, and cancer treatment side effects.
Collection
[
|
...
]